Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2011-12-29

Clinical Trial Update: Reduction of Spontaneous Prematurity by Antibiotic Treatment (Josamycin) [Phase 3]

View source ↗

Summary

A Phase 3 trial evaluating josamycin to reduce spontaneous preterm birth has completed. The update does not report results.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Josamycin (josamycin)

Snippet

Sponsor: Assistance Publique - Hôpitaux de Paris | Conditions: Prematurity | Phase 3 | Status: COMPLETED